Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 272

1.

4-month moxifloxacin containing regimens in the treatment of patients with sputum positive pulmonary tuberculosis in South India - a randomized clinical trial.

Velayutham B, Jawahar MS, Nair D, Navaneethapandian P, Ponnuraja C, Chandrasekaran K, Narayan Sivaramakrishnan G, Kumar MM, Kumaran PP, Kumar SR, Baskaran D, Devaleenal DB, Sirasanambati DR, Vasantha M, Palaniyandi P, Ramachandran G, Devi KRU, Hannah LE, Sekar G, Radhakrishnan A, Kalaiselvi D, Dhanalakshmi A, Thiruvalluvan E, Sakthivel MR, Mahilmaran A, Sridhar R, Jayabal L, Rathinam P, Angamuthu P, Ponnusamy KS, Venkatesan P, Natrajan M, Tripathy SP, Swaminathan S.

Trop Med Int Health. 2020 Jan 14. doi: 10.1111/tmi.13371. [Epub ahead of print]

PMID:
31944502
2.

Can affordability and innovation coexist for medicines?

Colbert A, Rintoul A, Simão M, Hill S, Swaminathan S.

BMJ. 2020 Jan 13;368:l7058. doi: 10.1136/bmj.l7058. No abstract available.

3.

Catastrophic costs due to tuberculosis in South India: comparison between active and passive case finding.

Muniyandi M, Thomas BE, Karikalan N, Kannan T, Rajendran K, Dolla CK, Saravanan B, Tholkappian AS, Tripathy SP, Swaminathan S.

Trans R Soc Trop Med Hyg. 2019 Dec 10. pii: trz127. doi: 10.1093/trstmh/trz127. [Epub ahead of print]

PMID:
31820812
4.

Isolation and comparative genomics of Mycobacterium tuberculosis isolates from cattle and their attendants in South India.

Palaniyandi K, Kumar N, Veerasamy M, Kabir Refaya A, Dolla C, Balaji S, Baskaran D, Thiruvengadam K, Rajendran A, Narayanan S, Raj D, Swaminathan S, Peacock SJ.

Sci Rep. 2019 Nov 29;9(1):17892. doi: 10.1038/s41598-019-54268-x.

5.

Monitoring the health-related Sustainable Development Goals: lessons learned and recommendations for improved measurement.

Asma S, Lozano R, Chatterji S, Swaminathan S, de Fátima Marinho M, Yamamoto N, Varavikova E, Misganaw A, Ryan M, Dandona L, Minghui R, Murray CJL.

Lancet. 2020 Jan 18;395(10219):240-246. doi: 10.1016/S0140-6736(19)32523-1. Epub 2019 Nov 22. Review. No abstract available.

PMID:
31767190
6.

Current status of human papillomavirus vaccination in India's cervical cancer prevention efforts.

Sankaranarayanan R, Basu P, Kaur P, Bhaskar R, Singh GB, Denzongpa P, Grover RK, Sebastian P, Saikia T, Oswal K, Kanodia R, Dsouza A, Mehrotra R, Rath GK, Jaggi V, Kashyap S, Kataria I, Hariprasad R, Sasieni P, Bhatla N, Rajaraman P, Trimble EL, Swaminathan S, Purushotham A.

Lancet Oncol. 2019 Nov;20(11):e637-e644. doi: 10.1016/S1470-2045(19)30531-5. Review.

PMID:
31674322
7.

Setting priorities in child health research in India for 2016-2025: a CHNRI exercise undertaken by the Indian Council for Medical Research and INCLEN Trust.

Wazny K, Arora NK, Mohapatra A, Gopalan HS, Das MK, Nair M, Bavdekar S, Rasaily R, Thavaraj V, Roy M, Shekhar C, Kumar R, Katoch VM, Rudan I, Black RE, Swaminathan S.

J Glob Health. 2019 Dec;9(2):020701. doi: 10.7189/jogh.09.020701.

8.

Correction: Tuberculosis patients in an Indian mega-city: Where do they live and where are they diagnosed?

Subbaraman R, Thomas BE, Sellappan S, Suresh C, Jayabal L, Lincy S, Raja AL, McFall A, Solomon SS, Mayer KH, Swaminathan S.

PLoS One. 2019 Oct 30;14(10):e0224808. doi: 10.1371/journal.pone.0224808. eCollection 2019.

9.

Whole-Genome Sequencing of a Mycobacterium orygis Strain Isolated from Cattle in Chennai, India.

Refaya AK, Kumar N, Raj D, Veerasamy M, Balaji S, Shanmugam S, Rajendran A, Tripathy SP, Swaminathan S, Peacock SJ, Palaniyandi K.

Microbiol Resour Announc. 2019 Oct 3;8(40). pii: e01080-19. doi: 10.1128/MRA.01080-19.

10.

Three-way partnerships fuel primary health care success.

Ghaffar A, Swaminathan S, Gupta A, Peterson SS, Bishai D.

BMJ Glob Health. 2019 Aug 16;4(Suppl 8):e001579. doi: 10.1136/bmjgh-2019-001579. eCollection 2019. No abstract available.

11.

Need for alternatives to animals in experimentation: An Indian perspective.

Swaminathan S, Kumar V, Kaul R.

Indian J Med Res. 2019 May;149(5):584-592. doi: 10.4103/ijmr.IJMR_2047_17. No abstract available.

12.

Strategies for ending tuberculosis in the South-East Asian Region: A modelling approach.

Arinaminpathy N, Mandal S, Bhatia V, McLeod R, Sharma M, Swaminathan S, Hyder KA, Mandal PP, Sarkar SK, Singh PK.

Indian J Med Res. 2019 Apr;149(4):517-527. doi: 10.4103/ijmr.IJMR_1901_18.

13.

Biomedical research; what gets funded where?

Adam T, Ralaidovy AH, Swaminathan S.

Bull World Health Organ. 2019 Aug 1;97(8):516-516A. doi: 10.2471/BLT.19.240499. No abstract available.

14.

Infection free "resisters" among household contacts of adult pulmonary tuberculosis.

Mave V, Chandrasekaran P, Chavan A, Shivakumar SVBY, Danasekaran K, Paradkar M, Thiruvengadam K, Kinikar A, Murali L, Gaikwad S, Hanna LE, Kulkarni V, Pattabiraman S, Suryavanshi N, Thomas B, Kohli R, Sivaramakrishnan GN, Pradhan N, Bhanu B, Kagal A, Golub J, Gandhi N, Gupte A, Gupte N, Swaminathan S, Gupta A; CTRIUMPH RePORT India Study Team.

PLoS One. 2019 Jul 18;14(7):e0218034. doi: 10.1371/journal.pone.0218034. eCollection 2019.

15.

Tuberculosis Control: WHO Perspective and Guidelines.

Kanchar A, Swaminathan S.

Indian J Pediatr. 2019 Aug;86(8):703-706. doi: 10.1007/s12098-019-02989-2. Epub 2019 Jun 25. Review. No abstract available.

PMID:
31240568
16.

In vitro interaction profiles of the new antitubercular drugs bedaquiline and delamanid with moxifloxacin against clinical Mycobacterium tuberculosis isolates.

Chandramohan Y, Padmanaban V, Bethunaickan R, Tripathy S, Swaminathan S, Ranganathan UD.

J Glob Antimicrob Resist. 2019 Dec;19:348-353. doi: 10.1016/j.jgar.2019.06.013. Epub 2019 Jun 18.

PMID:
31226332
17.

Multifocal tuberculosis-associated immune reconstitution inflammatory syndrome - a case report of a complicated scenario.

Narendran G, Oliveira-de-Souza D, Vinhaes CL, Akrami K, Fukutani KF, Banu K, Chandrasekaran P, Ravichandran N, Sereti I, Swaminathan S, Andrade BB.

BMC Infect Dis. 2019 Jun 17;19(1):529. doi: 10.1186/s12879-019-4182-1.

18.

Author Correction: Differential expression of CXCR3 and CCR6 on CD4+ T-lymphocytes with distinct memory phenotypes characterizes tuberculosis-associated immune reconstitution inflammatory syndrome.

Silveira-Mattos PS, Narendran G, Akrami K, Fukutani KF, Anbalagan S, Nayak K, Subramanyam S, Subramani R, Vinhaes CL, Souza DO, Antonelli LR, Satagopan K, Porter BO, Sher A, Swaminathan S, Sereti I, Andrade BB.

Sci Rep. 2019 May 24;9(1):8036. doi: 10.1038/s41598-019-44429-3.

19.

Hard to study, hard to treat: putting children at the centre of antibiotic research and development.

Balasegaram M, Pécoul B, Gray G, Sharland M, Swaminathan S.

Lancet Infect Dis. 2019 Jun;19(6):573-574. doi: 10.1016/S1473-3099(19)30214-2. No abstract available.

PMID:
31122767
20.

Sub-therapeutic rifampicin concentration is associated with unfavourable tuberculosis treatment outcomes.

Ramachandran G, Chandrasekaran P, Gaikwad S, Hemanth Kumar AK, Thiruvengadam K, Gupte N, Paradkar M, Dhanasekaran K, Sivaramakrishnan GN, Kagal A, Thomas B, Pradhan N, Kadam D, Hanna LE, Balasubramanian U, Kulkarni V, Murali L, Golub J, Gupte A, Shivakumar SVBY, Swaminathan S, Dooley KE, Gupta A, Mave V; C-TRIUMPh team.

Clin Infect Dis. 2019 May 10. pii: ciz380. doi: 10.1093/cid/ciz380. [Epub ahead of print]

PMID:
31075166
21.

Gender mainstreaming within WHO: not without equity and human rights.

Magar V, Heidari S, Zamora G, Coates A, Simelela PN, Swaminathan S.

Lancet. 2019 Apr 27;393(10182):1678-1679. doi: 10.1016/S0140-6736(19)30763-9. No abstract available.

PMID:
31034360
22.

How to shape research to advance global health.

Swaminathan S.

Nature. 2019 May;569(7754):7. doi: 10.1038/d41586-019-01235-1. No abstract available.

PMID:
31028359
23.

Association between anthropometric-based and food-based nutritional failure among children in India, 2015.

Joe W, Rajpal S, Kim R, Laxmaiah A, Harikumar R, Arlappa N, Meshram I, Balakrishna N, Radhika M, Swaminathan S, Subramanian SV.

Matern Child Nutr. 2019 Oct;15(4):e12830. doi: 10.1111/mcn.12830. Epub 2019 May 23.

PMID:
30989801
24.

Genome Sequencing of Polydrug-, Multidrug-, and Extensively Drug-Resistant Mycobacterium tuberculosis Strains from South India.

Shanmugam S, Kumar N, Nair D, Natrajan M, Tripathy SP, Peacock SJ, Swaminathan S, Ranganathan UD.

Microbiol Resour Announc. 2019 Mar 21;8(12). pii: e01388-18. doi: 10.1128/MRA.01388-18.

25.

Induction and maintenance of bi-functional (IFN-γ + IL-2+ and IL-2+ TNF-α+) T cell responses by DNA prime MVA boosted subtype C prophylactic vaccine tested in a Phase I trial in India.

Munusamy Ponnan S, Pattabiram S, Thiruvengadam K, Goyal R, Singla N, Mukherjee J, Chatrath S, Bergin P, T Kopycinski J, Gilmour J, Kumar S, Muthu M, Subramaniam S, Swaminathan S, Prasad Tripathy S, Luke HE.

PLoS One. 2019 Mar 28;14(3):e0213911. doi: 10.1371/journal.pone.0213911. eCollection 2019.

26.

Building a tuberculosis-free world: The Lancet Commission on tuberculosis.

Reid MJA, Arinaminpathy N, Bloom A, Bloom BR, Boehme C, Chaisson R, Chin DP, Churchyard G, Cox H, Ditiu L, Dybul M, Farrar J, Fauci AS, Fekadu E, Fujiwara PI, Hallett TB, Hanson CL, Harrington M, Herbert N, Hopewell PC, Ikeda C, Jamison DT, Khan AJ, Koek I, Krishnan N, Motsoaledi A, Pai M, Raviglione MC, Sharman A, Small PM, Swaminathan S, Temesgen Z, Vassall A, Venkatesan N, van Weezenbeek K, Yamey G, Agins BD, Alexandru S, Andrews JR, Beyeler N, Bivol S, Brigden G, Cattamanchi A, Cazabon D, Crudu V, Daftary A, Dewan P, Doepel LK, Eisinger RW, Fan V, Fewer S, Furin J, Goldhaber-Fiebert JD, Gomez GB, Graham SM, Gupta D, Kamene M, Khaparde S, Mailu EW, Masini EO, McHugh L, Mitchell E, Moon S, Osberg M, Pande T, Prince L, Rade K, Rao R, Remme M, Seddon JA, Selwyn C, Shete P, Sachdeva KS, Stallworthy G, Vesga JF, Vilc V, Goosby EP.

Lancet. 2019 Mar 30;393(10178):1331-1384. doi: 10.1016/S0140-6736(19)30024-8. Epub 2019 Mar 20. Review. No abstract available.

PMID:
30904263
27.

Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial.

Padmapriyadarsini C, Bhavani PK, Natrajan M, Ponnuraja C, Kumar H, Gomathy SN, Guleria R, Jawahar SM, Singh M, Balganesh T, Swaminathan S.

BMJ Open. 2019 Mar 1;9(3):e024363. doi: 10.1136/bmjopen-2018-024363.

28.

Evidence for Highly Variable, Region-Specific Patterns of T-Cell Epitope Mutations Accumulating in Mycobacterium tuberculosis Strains.

Ramaiah A, Nayak S, Rakshit S, Manson AL, Abeel T, Shanmugam S, Sahoo PN, John AJUK, Sundaramurthi JC, Narayanan S, D'Souza G, von Hoegen P, Ottenhoff THM, Swaminathan S, Earl AM, Vyakarnam A.

Front Immunol. 2019 Feb 13;10:195. doi: 10.3389/fimmu.2019.00195. eCollection 2019.

29.

Countdown Global Mental Health 2030.

Saxena S, Kestel D, Sunkel C, London E, Horton R, Patel V, Swaminathan S.

Lancet. 2019 Mar 2;393(10174):858-859. doi: 10.1016/S0140-6736(19)30424-6. Epub 2019 Feb 21. No abstract available.

PMID:
30799060
30.

Differential expression of CXCR3 and CCR6 on CD4+ T-lymphocytes with distinct memory phenotypes characterizes tuberculosis-associated immune reconstitution inflammatory syndrome.

Silveira-Mattos PS, Narendran G, Akrami K, Fukutani KF, Anbalagan S, Nayak K, Subramanyam S, Subramani R, Vinhaes CL, Souza DO, Antonelli LR, Satagopan K, Porter BO, Sher A, Swaminathan S, Sereti I, Andrade BB.

Sci Rep. 2019 Feb 6;9(1):1502. doi: 10.1038/s41598-018-37846-3. Erratum in: Sci Rep. 2019 May 24;9(1):8036.

31.

A new tuberculosis vaccine: breakthrough, challenges, and a call for collaboration.

Vekemans J, Gebreselassie N, Zignol M, Friede M, Kasaeva T, Swaminathan S.

Lancet Infect Dis. 2019 Feb;19(2):123-125. doi: 10.1016/S1473-3099(19)30003-9. Epub 2019 Jan 30. No abstract available.

PMID:
30712831
32.

Cross Type Neutralizing Antibodies Detected in a Unique HIV-2 Infected Individual From India.

Vidyavijayan KK, Cheedarala N, Babu H, Precilla LK, Sathyamurthi P, Chandrasekaran P, Murugavel KG, Swaminathan S, Tripathy SP, Hanna LE.

Front Immunol. 2018 Dec 17;9:2841. doi: 10.3389/fimmu.2018.02841. eCollection 2018.

33.

Up for debate - WHO guidelines on prompt release of outbreak data.

Moorthy V, Salama P, Swaminathan S.

Nature. 2018 Dec;564(7736):345. doi: 10.1038/d41586-018-07803-1. No abstract available.

PMID:
30568212
34.

Long-term virological outcome in children receiving first-line antiretroviral therapy.

Chandrasekaran P, Shet A, Srinivasan R, Sanjeeva GN, Subramanyan S, Sunderesan S, Ramesh K, Gopalan B, Suresh E, Poornagangadevi N, Hanna LE, Chandrasekar C, Wanke C, Swaminathan S.

AIDS Res Ther. 2018 Nov 26;15(1):23. doi: 10.1186/s12981-018-0208-9.

35.

National ethical guidelines for biomedical & health research involving human participants, 2017: A commentary.

Mathur R, Swaminathan S.

Indian J Med Res. 2018 Sep;148(3):279-283. doi: 10.4103/0971-5916.245303.

36.

After Astana: building the economic case for increased investment in primary health care.

Kluge H, Kelley E, Swaminathan S, Yamamoto N, Fisseha S, Theodorakis PN, Kristensen S, Anderson M, Mossialos E.

Lancet. 2018 Nov 17;392(10160):2147-2152. doi: 10.1016/S0140-6736(18)32859-9. Epub 2018 Nov 9. No abstract available.

PMID:
30420124
37.

Effect of moxifloxacin on QTc interval in adults with pulmonary tuberculosis.

Nair D, Velayutham B, Marimuthu M, Navaneethapandian PGD, Chinnaiyan P, Jawahar MS, Swaminathan S.

Natl Med J India. 2018 Jan-Feb;31(1):58-59. doi: 10.4103/0970-258X.243427. No abstract available.

38.

Mapping of Neutralizing Antibody Epitopes on the Envelope of Viruses Obtained from Plasma Samples Exhibiting Broad Cross-Clade Neutralization Potential Against HIV-1.

Cheedarla N, Sundaramurthi JC, Hemalatha B, Anangi B, Nesakumar M, Ashokkumar M, Vidya Vijayan KK, Tripathy SP, Swaminathan S, Vaniambadi SK, Ramanathan DV, Hanna LE.

AIDS Res Hum Retroviruses. 2019 Feb;35(2):169-184. doi: 10.1089/AID.2018.0224. Epub 2018 Dec 20.

PMID:
30328700
39.

Reimagining Development Assistance for Health.

Gupta V, Katz R, Swaminathan S.

N Engl J Med. 2018 Nov 15;379(20):1891-1893. doi: 10.1056/NEJMp1809808. Epub 2018 Sep 26. No abstract available.

PMID:
30256712
40.

Stemming the Wave of Cervical Cancer: Human Papillomavirus Vaccine Introduction in India.

Mehrotra R, Hariprasad R, Rajaraman P, Mahajan V, Grover R, Kaur P, Swaminathan S.

J Glob Oncol. 2018 Sep;4:1-4. doi: 10.1200/JGO.17.00030. Epub 2017 Sep 8. No abstract available.

41.

National Ethical Guidelines for Biomedical and Health Research Involving Human Participants, 2017: A commentary.

Mathur R, Swaminathan S.

Indian J Med Ethics. 2018 Jul-Sep;3(3):201-204. doi: 10.20529/IJME.2018.065.

42.

Upfront Xpert MTB/RIF testing on various specimen types for presumptive infant TB cases for early and appropriate treatment initiation.

Raizada N, Khaparde SD, Rao R, Kalra A, Sarin S, Salhotra VS, Swaminathan S, Khanna A, Chopra KK, Hanif M, Singh V, Umadevi KR, Nair SA, Huddart S, Tripathi R, Surya Prakash CH, Saha BK, Denkinger CM, Boehme C.

PLoS One. 2018 Aug 30;13(8):e0202085. doi: 10.1371/journal.pone.0202085. eCollection 2018.

43.

Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in India.

Munusamy Ponnan S, Swaminathan S, Tiruvengadam K, K K V, Cheedarla N, Nesakumar M, Kathirvel S, Goyal R, Singla N, Mukherjee J, Bergin P, T Kopycinski J, Gilmour J, Prasad Tripathy S, Luke HE.

PLoS One. 2018 Aug 29;13(8):e0203037. doi: 10.1371/journal.pone.0203037. eCollection 2018. Erratum in: PLoS One. 2018 Sep 19;13(9):e0204476.

44.

Mapping of health research funding in India.

Dandona L, Dandona R, Kumar GA, Cowling K, Titus P, Katoch VM, Swaminathan S.

Natl Med J India. 2017 Nov-Dec;30(6):309-316. doi: 10.4103/0970-258X.239069.

45.

Making diagnostic tests as essential as medicines.

Velazquez Berumen A, Garner S, Hill SR, Swaminathan S.

BMJ Glob Health. 2018 Aug 3;3(4):e001033. doi: 10.1136/bmjgh-2018-001033. eCollection 2018. No abstract available.

46.

Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting.

Chandrasekaran P, Mave V, Thiruvengadam K, Gupte N, Shivakumar SVBY, Hanna LE, Kulkarni V, Kadam D, Dhanasekaran K, Paradkar M, Thomas B, Kohli R, Dolla C, Bharadwaj R, Sivaramakrishnan GN, Pradhan N, Gupte A, Murali L, Valvi C, Swaminathan S, Gupta A; CTRIUMPH Study Team.

PLoS One. 2018 Aug 1;13(8):e0199360. doi: 10.1371/journal.pone.0199360. eCollection 2018.

47.

The drugs don't work: WHO's role in advancing new antibiotics.

Beyer P, Moorthy V, Paulin S, Hill SR, Sprenger M, Garner S, Simão M, Guerra R, Magrini N, Swaminathan S.

Lancet. 2018 Jul 28;392(10144):264-266. doi: 10.1016/S0140-6736(18)31570-8. No abstract available.

PMID:
30064640
48.

A randomized clinical efficacy trial of a psychosocial intervention to strengthen self-acceptance and reduce HIV risk for MSM in India: study protocol.

Mimiaga MJ, Thomas B, Mayer KH, Regenauer KS, Dange A, Andres Bedoya C, Rawat S, Balu V, O'Cleirigh C, Biello KB, Anand V, Swaminathan S, Safren SA.

BMC Public Health. 2018 Jul 18;18(1):890. doi: 10.1186/s12889-018-5838-2.

49.

Intrapatient variability in plasma rifampicin & isoniazid in tuberculosis patients.

Kumar AKH, Chandrasekaran V, Kannan T, Lavanya J, Swaminathan S, Ramachandran G.

Indian J Med Res. 2018 Mar;147(3):287-292. doi: 10.4103/ijmr.IJMR_1961_16.

50.

Evolution of Neutralization Response in HIV-1 Subtype C-Infected Individuals Exhibiting Broad Cross-Clade Neutralization of HIV-1 Strains.

Cheedarla N, Hemalatha B, Anangi B, Muthuramalingam K, Selvachithiram M, Sathyamurthi P, Kailasam N, Varadarajan R, Swaminathan S, Tripathy SP, Vaniambadi SK, Vadakkupattu DR, Hanna LE.

Front Immunol. 2018 Mar 27;9:618. doi: 10.3389/fimmu.2018.00618. eCollection 2018.

Supplemental Content

Loading ...
Support Center